TrialClinical and translational science2025

Pharmacokinetics and Pharmacodynamics of KT-474, a Novel Selective Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degrader, in Healthy Adults.

Sagar Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.